TickerFactsScreenerDevelopers

IOVANCE BIOTHERAPEUTICS, INC. (IOVA) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2007: $02008: $2.9K2009: $8.3K2010: $1.29M2011: $510.2K2012: $02013: $19.67M2014: $44.91M2015: $33.59M2016: $106.72M2017: $145.37M2018: $82.15M2019: $13.97M2020: $67.33M2021: $78.23M2022: $231.73M2023: $114.89M2024: $115.69M2025: $163.08M$163.08M
2007Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$163.08M+41.0%
2024$115.69M+0.7%
2023$114.89M-50.4%
2022$231.73M+196.2%
2021$78.23M+16.2%
2020$67.33M+382.0%
2019$13.97M-83.0%
2018$82.15M-43.5%
2017$145.37M+36.2%
2016$106.72M+217.7%
2015$33.59M-25.2%
2014$44.91M+128.3%
2013$19.67M—
2012$0-100.0%
2011$510.2K-60.5%
2010$1.29M+15553.0%
2009$8.3K+184.2%
2008$2.9K—
2007$0—